Search
Veeda Biopharma offers clinical bioanalysis services for method development, validation, and sample analysis using state-of-the-art LC-MS/MS and Ligand Binding Assay platforms (ELISA and ECL) for bioanalysis of biotherapeutics, meeting the needs of clients involved in drug development and regulatory submissions utilizing robust, sensitive, specific and reproducible methods.
Quantify Free/Bound/Total
Drug Concentrations in Biological Matrices
Analysis of Anti-Drug Antibodies (ADAs)
Using Tier-Based Approach
Screening
Confirmatory
Titer
Neutralizing Antibody (NAb)
Detection – Cell-Based or
Competitive Ligand Binding (CLB) Assays
Biomarker
Estimations
Veeda Biopharma accelerates vaccine development with rapid, high-quality immunogenicity testing for bacterial and viral vaccines. Our innovative immuno-analytical methods ensure precise results, focusing on humoral and cell-mediated immune responses, helping you achieve the highest scientific standards for your vaccine programs.
We offer specialized critical reagent development services to ensure the accuracy and consistency of your Ligand Binding Assays. By leveraging advanced characterization techniques, we optimize reagents for specificity, affinity, stability, and purity, enabling precise and reproducible measurements of target analytes in biological samples.
Generation
Purification
Labelling of Critical Reagents
Qualification
Clinical Bioanalysis team utilizes a robust Quality Management System (QMS) to ensure the highest quality data at every stage of analysis, providing the accountability and traceability necessary for regulatory submissions. Our bioanalytical services are conducted in GCLP-compliant laboratories, adhering to stringent regulatory guidelines from ICH, FDA, EMA, and current industry whitepapers.
AB SCIEX QTRAP 6500+
BioTek Synergy H1
MSD QuickPlex SQ 120